Procore beats estimates for Q3 revenue, earnings
Carpinteria-based Procore reported more losses in the third quarter of 2022, but continued revenue growth and a positive outlook keeps many investors bullish on the construction software company. Procore announced its third quarter earnings after the markets closed Nov. 2. The company reported a net loss of $71.2 million, up from a net loss of Read More →
Deckers shares flat despite earnings and revenue growth
Goleta-based Deckers Brands’ second quarter 2022 soundly beat analysts’ expectations in both revenue and earnings, but the company did not raise its guidances for the full fiscal year, giving investors some caution moving forward. Deckers, which owns Ugg, Hoka One One and other footwear brands, generated net income of $101 million for the quarter, or Read More →
Real Estate: Thousand Oaks office manager pleads guilty to embezzlement; celebrity home sells in Carpinteria
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Lease auction set for Morro Bay wind farm
In a little more than six weeks, more than 40 companies will bid on the first-ever offshore wind lease sale on the West Coast, competing for the right to build floating offshore wind farms off the coast of Morro Bay and elsewhere. The U.S. Department of the Interior announced Oct. 18 that the Bureau of Read More →
Merger of U.S. Bank and Union Bank gets final U.S. approval
U.S. Bank’s $8 billion acquisition of Union Bank has the green light from U.S. regulators, a big step forward for a deal that could make U.S. Bank one of the biggest retail banking companies in the tri-county region. The deal received its final U.S. regulatory approvals on Oct. 14, more than a year after it Read More →
SoCalGas compressor project in Ventura to get closer look from regulators
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen shares up amid optimism over experimental weight-loss drug
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
